<?xml version="1.0" encoding="UTF-8"?>
<p class="p">To overcome the drawbacks of EOs, such as high volatility, easy degradation, high lipophilicity and poor membrane permeability, several researchers have suggested the encapsulation of these active ingredients into nanocarriers [
 <xref rid="B11-pharmaceutics-09-00048" ref-type="bibr" class="xref">11</xref>].
</p>
